Efficacy and safety of intravitreal injection of triamcinolone acetonide as treatment for diffuse diabetic macular edema;Evaluación de la eficacia y seguridad de la inyección intravítrea de acetónido de triamcinolona en el tratamiento del edema de mácula difuso del diabético

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 84, Issue 11, 2009, Pages 547-

  Lopez Galvez M I ^a   Pastor Jimeno, J C ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

DIABETIC RETINOPATHY; EDITORIAL; HUMAN; INJECTION; RETINA MACULA EDEMA; VITREOUS BODY;

DIABETIC RETINOPATHY; HUMANS; INJECTIONS; MACULAR EDEMA; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 77952421417     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Pastor JC. Investigación clínica independiente: es posible. Arch Soc Esp Oftalmol 2006; 81: 133-134.
2. Beck RW, Edwards AR, Aiello LP, Bressler NM, Ferris F, Glassman AR, et al. Triamcinolone acetonide and Focal/Grid photocoagulation for diabetic macular edema. Ophthalmology 2008; 115: 1447-1459.
3. Maia O, Takahashi B, Costa R, Scott I, Takahashi W. Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial. Am J Ophthalmol 2009; 147: 291-297.